A citation-based method for searching scientific literature

Yunjuan Zhao, Lin Yang, Zhiguang Zhou. J Diabetes 2014
Times Cited: 18







List of co-cited articles
146 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
22

Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.
Junichi Matsubara, Seigo Sugiyama, Eiichi Akiyama, Satomi Iwashita, Hirofumi Kurokawa, Keisuke Ohba, Hirofumi Maeda, Koichiro Fujisue, Eiichiro Yamamoto, Koichi Kaikita,[...]. Circ J 2013
147
22


The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients.
Shlomit Koren, Lital Shemesh-Bar, Amit Tirosh, Ronit Koren Peleg, Sylvia Berman, Ramzia Abu Hamad, Shlomo Vinker, Ahuva Golik, Shai Efrati. Diabetes Technol Ther 2012
51
16

Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes.
A J Tremblay, B Lamarche, C F Deacon, S J Weisnagel, P Couture. Diabetes Obes Metab 2011
122
16

Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
269
16

Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Lei Tian, Jie Gao, Jianqiang Hao, Yu Zhang, Huimin Yi, Timothy D O'Brien, Robert Sorenson, Jian Luo, Zhiguang Guo. Endocrinology 2010
89
16

Dipeptidyl peptidase 4 inhibitor sitagliptin maintains β-cell function in patients with recent-onset latent autoimmune diabetes in adults: one year prospective study.
Yunjuan Zhao, Lin Yang, Yufei Xiang, Lingjiao Liu, Gan Huang, Zhaofeng Long, Xia Li, R David Leslie, Xiangbing Wang, Zhiguang Zhou. J Clin Endocrinol Metab 2014
74
16

The new insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes.
Yunjuan Zhao, Lin Yang, Xiangbing Wang, Zhiguang Zhou. Diabetes Metab Res Rev 2014
39
16

Effect of sitagliptin on post-prandial glucagon and GLP-1 levels in patients with type 1 diabetes: investigator-initiated, double-blind, randomized, placebo-controlled trial.
Satish K Garg, Emily G Moser, Bruce W Bode, Leslie J Klaff, William R Hiatt, Christie Beatson, Janet K Snell-Bergeon. Endocr Pract 2013
68
16

Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition.
Swenja Kröller-Schön, Maike Knorr, Michael Hausding, Matthias Oelze, Alexandra Schuff, Richard Schell, Stephan Sudowe, Alexander Scholz, Steffen Daub, Susanne Karbach,[...]. Cardiovasc Res 2012
130
16

Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme.
Odd Erik Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel, Hans-Juergen Woerle. Cardiovasc Diabetol 2012
168
16



Insulin sensitizing and anti-inflammatory effects of thiazolidinediones are heightened in obese patients.
Yonah B Esterson, Kehao Zhang, Sudha Koppaka, Sylvia Kehlenbrink, Preeti Kishore, Pooja Raghavan, Sylvan Roger Maginley, Michelle Carey, Meredith Hawkins. J Investig Med 2013
23
16

Cardiovascular effects of gliptins.
André J Scheen. Nat Rev Cardiol 2013
120
16

Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
Kikuo Isoda, James L Young, Andreas Zirlik, Lindsey A MacFarlane, Naotake Tsuboi, Norbert Gerdes, Uwe Schönbeck, Peter Libby. Arterioscler Thromb Vasc Biol 2006
333
16

Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes.
Xiao-Ming Mao, Hao Liu, Xiao-Jun Tao, Guo-Ping Yin, Qian Li, Shu-Kui Wang. Diabetes Metab Res Rev 2009
14
21

The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis.
Yulan Zhao, Xuelian He, Chengjin Huang, Xiaonan Fu, Xuegui Shi, Ying Wu, Yijie Han, Naishi Li, Yanxiang Wu, Chew-Kiat Heng. Diabetes Res Clin Pract 2010
12
25

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells.
Aya Shiraki, Jun-ichi Oyama, Hiroshi Komoda, Machiko Asaka, Aiko Komatsu, Masashi Sakuma, Kazuhisa Kodama, Yoshiko Sakamoto, Norihiko Kotooka, Tetsuaki Hirase,[...]. Atherosclerosis 2012
168
16



The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.
Thomas Schöndorf, Petra B Musholt, Cloth Hohberg, Thomas Forst, Ute Lehmann, Winfried Fuchs, Mirjam Löbig, Jürgen Müller, Andreas Pfützner. J Diabetes Sci Technol 2011
19
16

Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice.
Atsuo Tahara, Eiji Kurosaki, Masanori Yokono, Daisuke Yamajuku, Rumi Kihara, Yuka Hayashizaki, Toshiyuki Takasu, Masakazu Imamura, Qun Li, Hiroshi Tomiyama,[...]. Eur J Pharmacol 2013
184
16

Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance.
Steven Haffner, Marinella Temprosa, Jill Crandall, Sarah Fowler, Ronald Goldberg, Edward Horton, Santica Marcovina, Kieren Mather, Trevor Orchard, Robert Ratner,[...]. Diabetes 2005
211
16

Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis.
Sathish Babu Vasamsetti, Santosh Karnewar, Anantha Koteswararao Kanugula, Avinash Raj Thatipalli, Jerald Mahesh Kumar, Srigiridhar Kotamraju. Diabetes 2015
200
16

DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway.
Yao Dai, Dongsheng Dai, Xianwei Wang, Zufeng Ding, Jawahar L Mehta. Cardiovasc Drugs Ther 2014
68
16

Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis.
E Boettcher, G Csako, F Pucino, R Wesley, R Loomba. Aliment Pharmacol Ther 2012
177
16

Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Giuseppe Derosa, Pamela Maffioli, Sibilla A T Salvadeo, Ilaria Ferrari, Pietro D Ragonesi, Fabrizio Querci, Ivano G Franzetti, Gennaro Gadaleta, Leonardina Ciccarelli, Mario N Piccinni,[...]. Metabolism 2010
90
16

Cardiovascular biology of the incretin system.
John R Ussher, Daniel J Drucker. Endocr Rev 2012
365
16

Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metformin.
Giuseppe Derosa, Anna Carbone, Angela D'Angelo, Fabrizio Querci, Elena Fogari, Arrigo F G Cicero, Pamela Maffioli. Intern Med 2013
24
16

Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
Yoshikazu Nitta, Nobuhiro Tahara, Atsuko Tahara, Akihiro Honda, Norihiro Kodama, Minori Mizoguchi, Hayato Kaida, Masatoshi Ishibashi, Naofumi Hayabuchi, Hisao Ikeda,[...]. JACC Cardiovasc Imaging 2013
40
16

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
16

A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.
Mika Nabeno, Fumihiko Akahoshi, Hiroyuki Kishida, Ikuko Miyaguchi, Yoshihito Tanaka, Shinichi Ishii, Takashi Kadowaki. Biochem Biophys Res Commun 2013
145
16


The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob/ob mice.
Christoph Schürmann, Andreas Linke, Kerstin Engelmann-Pilger, Cornelia Steinmetz, Michael Mark, Josef Pfeilschifter, Thomas Klein, Stefan Frank. J Pharmacol Exp Ther 2012
56
16


Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Silvio E Inzucchi, Richard M Bergenstal, John B Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L Peters, Apostolos Tsapas, Richard Wender, David R Matthews. Diabetes Care 2012
11

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
Jun Shirakawa, Hideki Fujii, Kei Ohnuma, Koichiro Sato, Yuzuru Ito, Mitsuyo Kaji, Eri Sakamoto, Megumi Koganei, Hajime Sasaki, Yoji Nagashima,[...]. Diabetes 2011
185
11


CD26, let it cut or cut it down.
I De Meester, S Korom, J Van Damme, S Scharpé. Immunol Today 1999
381
11

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?
Aleksi Sedo, Jonathan S Duke-Cohan, Eva Balaziova, Liliana R Sedova. Arthritis Res Ther 2005
57
11


Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice.
Michele D'Amico, Clara Di Filippo, Raffaele Marfella, Angela Maria Abbatecola, Franca Ferraraccio, Francesco Rossi, Giuseppe Paolisso. Exp Gerontol 2010
115
11


Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.
Hanne B Rasmussen, Sven Branner, Finn C Wiberg, Nicolai Wagtmann. Nat Struct Biol 2003
295
11

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Dooseop Kim, Liping Wang, Maria Beconi, George J Eiermann, Michael H Fisher, Huaibing He, Gerard J Hickey, Jennifer E Kowalchick, Barbara Leiting, Kathryn Lyons,[...]. J Med Chem 2005
564
11

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice.
Jacob Jelsing, Niels Vrang, Søren B van Witteloostuijn, Michael Mark, Thomas Klein. J Endocrinol 2012
38
11



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.